Zhang, Yanjun
Zeng, Gang
Pan, Hongxing
Li, Changgui
Hu, Yaling
Chu, Kai
Han, Weixiao
Chen, Zhen
Tang, Rong
Yin, Weidong
Chen, Xin
Hu, Yuansheng
Liu, Xiaoyong
Jiang, Congbing
Li, Jingxin
Yang, Minnan
Song, Yan
Wang, Xiangxi
Gao, Qiang
Zhu, Fengcai
Funding for this research was provided by:
Beijing Municipal Science and Technology Commission
Ministry of Science and Technology of the People's Republic of China
This article is maintained by: Elsevier
Article Title: Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Journal Title: The Lancet Infectious Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1473-3099(20)30843-4
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1473-3099(20)30870-7
Content Type: article
Copyright: © 2020 Elsevier Ltd. All rights reserved.